Screener
Altimmune ALT Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Altimmune’s reported figures.
Based on the most recent quarter.
The source filing: Altimmune’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
FAQ
- What is Altimmune's price / sales?
- Altimmune (ALT) reported price / sales of 9,187.2× in Q4 2025.
- How has Altimmune's price / sales changed year-over-year?
- Altimmune's price / sales decreased by 64.2% year-over-year, from 25,640.4× to 9,187.2×.
- What is the long-term trend for Altimmune's price / sales?
- Over 4 years (2020 to 2025), Altimmune's price / sales has grown at a 259.9% compound annual growth rate (CAGR), from 54.8× to 9,187.2×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Altimmune's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude